Piperazine derivatives as tachykinin antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 241/04 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 403/14 (2006.01) C07D 405/06 (2006.01) C07D 409/06 (2006.01) C07D 413/06 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 471/08 (2006.01) C07D 487/08 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2240835

This invention relates to piperazine derivatives of formula (I), wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to use of the same for treating or Tachykinin- mediated diseases in human being or animals.

L'invention porte sur des dérivés de la pipérazine de formule (I) dans laquelle chacun des symboles est défini dans la description, sur leurs sels pharmacocompatibles, sur des procédés servant à les préparer, sur des compositions pharmaceutiques les contenant, ainsi que sur leur emploi pour le traitement chez l'homme et l'animal de maladies dues à la tachykinine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazine derivatives as tachykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives as tachykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives as tachykinin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1847698

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.